Published in Adv Metab Disord on January 01, 1973
The role of abnormal hemorrheodynamics in the pathogenesis of diabetic retinopathy. Trans Am Ophthalmol Soc (1976) 1.07
Current concepts of pathogenesis of diabetic retinopathy: a dysproteinemia. Trans Am Ophthalmol Soc (1977) 0.83
Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58
Diabetes, diabetic angiopathy, and growth hormone. Lancet (1970) 1.56
Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia (1968) 1.17
Neuropathy in experimental diabetes: an animal model. Br Med J (1976) 1.12
Plasma-insulin in mild juvenile diabetes. Lancet (1967) 1.05
Fluorescence angiography of the iris in recent and long-term diabetes. Preliminary communication. Acta Ophthalmol (Copenh) (1968) 1.03
Some actions of growth hormone release inhibiting factor. Br Med J (1973) 0.98
Fluorescence angiography of the iris in recent and long-term diabetes. Diabetologia (1968) 0.94
Kidney lesions in rats with severe long term alloxan diabetes. 3. Glomerular ultrastructure. Lab Invest (1967) 0.86
Kidney lesions in rats with severe long-term alloxan diabetes. 2. Histochemical studies, comparison with human diabetic glomerular lesions. Acta Pathol Microbiol Scand (1966) 0.86
Somatostatin: clinical importance and outlook. Metabolism (1978) 0.86
The inhibition by somatostatin of the thyrotropin response to thyrotropin-releasing hormone in normal subjects. Scand J Clin Lab Invest (1974) 0.83
Diabetic cardiopathy. Diabetologia (1979) 0.82
Morphological abnormalities of the terminal neuromuscular apparatus in recent juvenile diabetes. Diabetologia (1970) 0.82
Growth hormone and diabetic angiopathy. Lancet (1970) 0.81
Pathological changes in the central and peripheral nervous system of young long-term diabetics. The terminal neuro-muscular apparatus. Diabetologia (1970) 0.81
Twenty-four-hour serum growth hormone levels in maturity-onset diabetics. Diabetes (1975) 0.79
The basement membrane controversy. Diabetologia (1978) 0.79
Somatostatin as a tool in studies of basal carbohydrate and lipid metabolism in man: modifications of glucagon and insulin release. Scand J Clin Lab Invest (1974) 0.79
Letter: Somatostatin and insulinoma. Lancet (1975) 0.79
The pathogenesis of diabetic angiopathy and growth hormone. Dan Med Bull (1971) 0.78
24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics. Diabetes (1978) 0.78
Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet (1976) 0.78
Early and late changes in the diabetic kidney. Adv Nephrol Necker Hosp (1979) 0.77
Growth hormone's role in diabetic microangiopathy. Diabetes (1976) 0.77
Metabolic and hormonal factors in diabetic retinopathy. Int Ophthalmol Clin (1978) 0.76
Somatostatin and the 24 h levels of serum TSH, T3, T4, and reverse T3 in normals, diabetics and patients treated for myxoedema. Acta Endocrinol (Copenh) (1980) 0.76
The diagnosis of insuloma. Acta Med Scand (1967) 0.76
Neuopathy in experimental diabetes. Br Med J (1976) 0.75
Factors controlling blood glucose--with remarks on the effect of insulin on muscle. Proc R Soc Med (1968) 0.75
[Renal structure and function in early and diabetes long-term]. Rev Med Suisse Romande (1970) 0.75
Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics. Metabolism (1978) 0.75
[Angiopathic neuropathy and metabolic neuropathy in diabetes]. Journ Annu Diabetol Hotel Dieu (1965) 0.75
[The NOVO prize 1970 to Professor Poul Astrup, M.D]. Nord Med (1970) 0.75
[Diabetic angiopathy, the diabetic kidney and diabetic macroangiopathy]. Minerva Med (1977) 0.75
The insulin-like activity in serum determined by the rat epididymal fat method. VI. Insulin-like activity in serum and serum-protein fractions from normal persons and patients with diabetes mellitus. Acta Med Scand (1966) 0.75
[Diabetic angiopathy]. Acta Diabetol Lat (1974) 0.75
Somatostatin in maturity-onset diabetes. Diabetes (1978) 0.75
Effects of somatostatin on basal levels of plasma growth hormone and insulin in acromegalics: dose-response studies and attempted total growth hormone suppression. J Clin Endocrinol Metab (1976) 0.75
The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients. Scand J Clin Lab Invest (1975) 0.75
Growth hormone and diabetic angiopathy. Acta Diabetol Lat (1971) 0.75
Kidney lesions in rats with severe long-term alloxan diabetes : I. Influence of age, alloxan damage, and insulin administration. Diabetologia (1966) 0.75
[Is there a possible role of a growth hormone hypersecretion in the course of the vascular complications of diabetes mellitus?]. Journ Annu Diabetol Hotel Dieu (1972) 0.75
[My field of research - Diabetology]. Nord Med (1968) 0.75
Recent contributions to the study of diabetic angiopathy and neuropathy. Adv Metab Disord (1972) 0.75
[Diabetic angiopathy. A new concept of pathogenesis (author's transl)]. MMW Munch Med Wochenschr (1977) 0.75
Diabetes mellitus and somatostatin. A review. Dan Med Bull (1977) 0.75
[Growth hormone, growth factors and diabetes mellitus]. Journ Annu Diabetol Hotel Dieu (1987) 0.75
The special role of diabetic angiopathy. Horm Metab Res (1974) 0.75
Diagnosis and treatment of pancreatic beta-cell tumor. Surg Annu (1975) 0.75
Growth hormone enhances basement membrane thickening in experimental diabetes. A preliminary report. Diabetologia (1978) 0.75
Nervous system abnormality and nervous disease in diabetes. Acta Endocrinol Suppl (Copenh) (1980) 0.75
Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin. Diabetologia (1978) 0.75
[Diabetes mellitus]. Ugeskr Laeger (1978) 0.75
Somatostatin in the treatment of patients with extra-pyramidal disorders and patients with EEG abnormalities. Acta Neurol Scand (1978) 0.75
[A Danish medical delegation in the people's republic of China]. Ugeskr Laeger (1975) 0.75
[Artificial sweeteners]. Tidsskr Sygepl (1969) 0.75
[Diabetic angiopathy]. Tidsskr Nor Laegeforen (1971) 0.75
[Diabetic angiopathies. The kidney and diabetic macroangiopathy]. Rev Clin Esp (1978) 0.75
Somatostatin: a review of its effects especially in human beings. Diabete Metab (1976) 0.75
[Glomerular changes in diabetes mellitus]. Nord Med (1979) 0.75
The clinical diagnosis of insulinoma. Scand J Gastroenterol Suppl (1979) 0.75
Anxiety, growth hormone and glucose tolerance in normal children. Acta Med Scand (1972) 0.75
[Diabetic angiopathy]. Dtsch Med J (1972) 0.75